Prentice Capital Management LP 13D and 13G filings for Immunome, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Immunome, Inc. IMNM | Prentice Capital Management LP | 498,145 4.110% | -421,917 (-45.86%) | Filing |
| 2022-02-14 4:30 pm Purchase | 2021-12-31 | 13G | Immunome, Inc. IMNM | Prentice Capital Management LP | 920,062 7.600% | 142,894 (+18.39%) | Filing |
| 2021-12-03 11:13 am Purchase | 2021-12-02 | 13G | Immunome, Inc. IMNM | Prentice Capital Management LP | 777,168 6.420% | 777,168 (New Position) | Filing |